Clinical Trials Logo

Self Efficacy clinical trials

View clinical trials related to Self Efficacy.

Filter by:

NCT ID: NCT04577365 Recruiting - Self Efficacy Clinical Trials

Validation of a New Scale of Balance Recovery Confidence for Community-dwelling Older Adults

Start date: February 22, 2021
Phase:
Study type: Observational

Introduction: Patient-reported outcome measures (PROMs) provide clinicians with a greater understanding of patients' perceived ability in their physical performance. Existing PROMs on falls efficacy provide meaningful information about the perceived ability in older people to perform common activities of daily living without falling. However, the perceived ability to recover the balance from a slip, a trip, or volitional movements has been inadequately assessed. Balance recovery confidence relates to the judgement of self-reactive ability. The scale of balance recovery confidence (BRC) is a new PROM that measures perceived balance recovery self-efficacy. The purpose of the study protocol is to describe the first psychometric evaluation of BRC's measurement properties. Methods and analysis: This study is a validation phase of a newly developed PROM conducted in Singapore. Two hundred community-dwelling older adults, aged 65 years and older, will complete five self-reported instruments (BRC), Activities-specific Balance Confidence Scale (ABC), Falls Efficacy Scale-International (FES-I), Late-Life Function and Disability Instrument-Function (LLDI-F) and Global Perceived Effect (GPE) and three performance measures (Hand strength dynamometer, 30-second Chair Stand, Mini BESTest). Classical test theory methods will assess acceptability, data completeness, targeting of the items, scaling assumptions, internal consistency reliability and construct validity. Factor analysis will establish unidimensionality. Rasch analysis will evaluate item fit, differential item functioning, response scale ordering, targeting of persons and items and the reliability.

NCT ID: NCT04537195 Recruiting - Depression Clinical Trials

Effects of a Lay-led Anxiety and Depression Self-management Program for Cancer Patients

ADSMP-C
Start date: March 6, 2020
Phase: N/A
Study type: Interventional

The investigators aim to evaluate a peer-to-peer patient self-management program targeting symptoms of anxiety and depression in a randomized trial. A total of 234 cancer patients recently having completed primary treatment with curative intent in central Region Denmark will be included. The intervention is a lay-led, group-based transdiagnostic patient education program consisting of seven 2 ½ hour weekly sessions focusing on increasing patient self-efficacy in symptom management of anxiety and depression. The intervention is highly structured and manualized.

NCT ID: NCT04371120 Recruiting - Clinical trials for Traumatic Brain Injury

Brain Injury Self-Efficacy Scale Validation

BICSQ
Start date: April 1, 2019
Phase:
Study type: Observational

The purpose of this study is to validate the Brain Injury Self-Efficacy Scale as a measure of self-efficacy in brain injury by comparing it with other measures of self-efficacy, the GSE, and PROMIS self-efficacy.

NCT ID: NCT04298424 Recruiting - Diabetes Clinical Trials

the Peer-Led Self-Management Program

Start date: February 14, 2020
Phase: N/A
Study type: Interventional

Elderly patients have the deficiency of motivation and confidence in self-management that are mainly influenced by physiological function, social psychology, emotion and low health literacy, resulting in poor self-management and glycemic control. According to the study, elderly patients can learn the skill of self-management more effectively through the peer leaders who have the same culture background, the life experience in disease care and the successful self-management experiences. The Self-Management Program of diabetes for the elderly will be in progress with the peer leadership concept.( the Peer-Led Self-Management Program). The aim of the pilot study was to explore the feasibility and effects of the Peer-Led Self-Management Program (PLSM). This pilot study uses two groups of block randomized controlled trials with pretest and posttest study. The test group will conduct a four-week Peer-Led Self-Management Program and the general outpatient care while the control group will implement the general outpatient care. In this study, the physiological parameters of Diabetes were used to evaluate the difference between the pre-and post-intervention measures.

NCT ID: NCT02830386 Recruiting - Self Efficacy Clinical Trials

Chinese Registry of Assisted Embolization for Ruptured Wide Necked Intracranial Aneurysm Using LVIS Stent

CRANIAL-2
Start date: June 2016
Phase: N/A
Study type: Observational

This study aims to investigating the efficacy and safety of low profile visualized intraluminal support (LVIS) stents for the treatment of ruptured intracranial saccular aneurysms. The follow-up duration is 1 year.

NCT ID: NCT02830373 Recruiting - Self Efficacy Clinical Trials

Chinese Registry of Assisted Embolization for Unruptured Wide Necked Intracranial Aneurysm Using LVIS Stent

CRANIAL-1
Start date: June 2016
Phase: N/A
Study type: Observational

This study aims to investigating the efficacy and safety of low profile visualized intraluminal support (LVIS) stents for the treatment of unruptured intracranial saccular aneurysms.

NCT ID: NCT01965275 Recruiting - Self Efficacy Clinical Trials

High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs

Start date: October 2013
Phase: Phase 2
Study type: Interventional

the purpose of this study is to evaluate the efficacy and safety of high-dose,pulsatile Erlotinib/Gefitinib in advanced non small cell lung cancer (NSCLC) patients after failure of standard dose EGFR-TKIs(Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors)

NCT ID: NCT01757366 Recruiting - Self Efficacy Clinical Trials

Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer

Start date: December 2012
Phase: Phase 2
Study type: Interventional

Safety and Efficacy of Ginsenoside Rg3 in Combination with First-line Chemotherapy in Advanced Gastric Cancer.The purpose of this study is to assess the safety of Ginsenoside Rg3 in advanced gastric cancer, and whether it improves the efficacy of first-line chemotherapy.

NCT ID: NCT01725906 Recruiting - Self Efficacy Clinical Trials

Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication

Start date: November 2012
Phase: Phase 4
Study type: Interventional

We aimed to compare the efficacy of genotypic resistance guided sequential therapy vs. empiric therapy in the third line therapy. Factors affecting the eradication rates, including the antibiotic resistance, CYP2C19 polymorphism, CagA and VacA status will also be assessed.

NCT ID: NCT01327729 Recruiting - Hepatitis C Clinical Trials

Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C

Start date: November 2010
Phase: Phase 2/Phase 3
Study type: Interventional

The objective is to assess the efficacy, dosing, safety and tolerance of Y- shaped pegylated interferon (YPEG-IFNα-2a) plus ribavirin in Egyptian patients with chronic hepatitis C and with no prior treatment for hepatitis C virus (HCV). Methods: Randomized, Open-label trial, in 3 parallel groups (each of 100 patients)